Irene Cetin
Advanced in Gonococcal Conjunctivitis

Irene Cetin

Milan, IT 
Advanced in Gonococcal Conjunctivitis
Milan, IT 
OverviewLocationsClinical Research

Overview

Irene Cetin practices in Milan, Italy. Ms. Cetin is rated as an Advanced expert by MediFind in the treatment of Gonococcal Conjunctivitis. Her top areas of expertise are Intrauterine Growth Restriction, Gonococcal Conjunctivitis, Gestational Diabetes, and Preeclampsia.

Her clinical research consists of co-authoring 253 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Gonococcal Conjunctivitis.

Gender
Female

Locations

Milan, Italy
Other Locations
Lodi, 26900, Italy
Segrate, 20054, Italy
Buzzi, Italy
Sacco, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Reactogenicity and Immune Response of a Single Intramuscular Dose of Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers
A Phase III, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Reactogenicity and Immune Response of a Single Intramuscular Dose of Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers
Enrollment Status: Terminated
Publish Date: April 20, 2025
Intervention Type: Biological, Drug
Study Phase: Phase 3
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
A Phase III, Randomized, Double-blind, Placebo-controlled Multi-country Study to Demonstrate Efficacy of a Single Dose of Unadjuvanted RSV Maternal Vaccine, Administered IM to Pregnant Women 18 to 49 Years of Age, for Prevention of RSV Associated LRTIs in Their Infants up to 6 Months of Age
Enrollment Status: Terminated
Publish Date: February 20, 2025
Intervention Type: Biological, Drug
Study Drug: RSV Maternal vaccine
Study Phase: Phase 3
View 1 Less Clinical Trial

253 Total Publications

Antibiotic Resistance in Breastfeeding Diseases: A Multidisciplinary Study in an Italian Level III Medical Center.
Antibiotic Resistance in Breastfeeding Diseases: A Multidisciplinary Study in an Italian Level III Medical Center.
Journal: Journal of human lactation : official journal of International Lactation Consultant Association
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cetin's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile